1. microRNAs Make the Call in Cancer Personalized Medicine
    Simone Detassis et al, 2017, Front. Cell Dev. Biol. CrossRef
  2. Deciphering the Breast Density Inform Law Movement: Implications for Practice.
    Sean D Raj et al, 2018, Semin Ultrasound CT MR CrossRef
  3. A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma
    Yue Wang et al, 2018, Current Problems in Cancer CrossRef
  4. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma
    Song Xu et al, 2018, Thorac Cancer CrossRef
  5. null
    Martina Faraldi et al, 2018 CrossRef
  6. Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer.
    Peng Zhang et al, 2018, Int J Exp Pathol CrossRef
  7. Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
    Carolyn Klinge, 2018, ncRNA CrossRef
  8. Clinical utility of microRNA-451 as diagnostic biomarker for human cancers
    Zhanzhan Li et al, 2019, Biosci. Rep. CrossRef
  9. miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
    Wenzhu Dai et al, 2019, J Breast Cancer CrossRef
  10. The microRNA‐141‐3p/ CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab
    Wenqing Song et al, 2019, J Cell Biochem CrossRef
  11. Integrative transcriptome data mining for identification of core lncRNAs in breast cancer
    Xiaoming Zhang et al, 2019 CrossRef
  12. MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9.
    Xinxin Zhang et al, 2020, Bone CrossRef
  13. Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility
    Monika Lesicka et al, 2019, IJMS CrossRef
  14. The role of upregulated miR-375 expression in breast cancer: an in vitro and in silico study
    Wei Tang et al, 2019, Pathology - Research and Practice CrossRef
  15. miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis.
    Carmen Elena Condrat et al, 2020, Cells CrossRef
  16. MicroRNA profiling of pancreatic ductal adenocarcinoma (PDAC) reveals signature expression related to lymph node metastasis
    Moran Lemberger et al, 2019, Oncotarget CrossRef
  17. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression
    Xiaohui Zhang et al, 2020, Sci Rep CrossRef
  18. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma
    Chang Gu et al, 2020, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics CrossRef
  19. Differentially expressed gene profile and relevant pathways of the traditional Chinese medicine cinobufotalin on MCF‑7 breast cancer cells
    Jie Li et al, 2019, Mol Med Report CrossRef
  20. Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
    Andrea Ritter et al, 2019, Int J Oncol CrossRef
  21. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map
    Zu‑Xuan Chen et al, 2018, Mol Med Report CrossRef
  22. MicroRNA-671-3p inhibits the development of breast cancer: A study based on in vitro experiments, in-house quantitative polymerase chain reaction and bioinformatics analysis.
    Dan-Dan Xiong et al, 0 CrossRef
  23. The emerging role of miRNA clusters in breast cancer progression
    Amoolya Kandettu et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  24. Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals
    Andrea Feliciano et al, 2020, Front. Oncol. CrossRef
  25. The Predictive Value of miR-16, -29a and -134 for Early Identification of Gestational Diabetes: A Nested Analysis of the DALI Cohort
    Anja Sørensen et al, 2021, Cells CrossRef
  26. A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression
    Rhafaela Lima Causin et al, 2021, Cells CrossRef
  27. Prediction of Novel miRNA Biomarker Candidates for Diagnostic and Prognostic Analysis of STAD and LIHC: An Integrated in silico Approach
    Kumkum Kar et al, 2021, Informatics in Medicine Unlocked CrossRef
  28. MicroRNA: Biogenesis and potential role as biomarkers in lung diseases
    Amit K. Verma et al, 2021, Meta Gene CrossRef
  29. microRNA ‐based diagnostic and therapeutic applications in cancer medicine
    Lorenzo F. Sempere et al, 2021, WIREs RNA CrossRef
  30. Role of Epigenetics in carcinogenesis: Recent Advancements in Anticancer Therapy
    Showket Hussain et al, 2021, Seminars in Cancer Biology CrossRef
  31. A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.
    Christos Kontos, 0 CrossRef
  32. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review
    Thuy Thi Chung Duong et al, 2022, Cancer Epidemiology CrossRef
  33. Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer
    Valentina K. Todorova et al, 2022, Current Oncology CrossRef
  34. null
    Rina Ningthoujam et al, 2022 CrossRef
  35. Pulmonary EV miRNA profiles identify disease and distinct inflammatory endotypes in COPD
    Hannah Burke et al, 2022, Front. Med. CrossRef
  36. MicroRNAs: Small Molecules with Significant Functions, Particularly in the Context of Viral Hepatitis B and C Infection
    Fayed Megahed et al, 2023, Medicina CrossRef
  37. Diagnostic and predictive value of liquid biopsy-derived exosome miR-21 for breast cancer: a systematic review and meta-analysis
    Miaomiao Wang et al, 2023, Expert Review of Molecular Diagnostics CrossRef
  38. Recent advances in novel miRNA mediated approaches for targeting breast cancer
    Seyedeh Melika Ahmadi et al, 2023, Journal of Drug Targeting CrossRef
  39. SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs
    Reyhaneh Rasizadeh et al, 2023, Virol J CrossRef
  40. null
    Mamta Panda et al, 2024 CrossRef